These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12412476)

  • 1. Simultaneous humanization and affinity optimization of monoclonal antibodies.
    Wu H
    Methods Mol Biol; 2003; 207():197-212. PubMed ID: 12412476
    [No Abstract]   [Full Text] [Related]  

  • 2. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanization and Simultaneous Optimization of Monoclonal Antibody.
    Kuramochi T; Igawa T; Tsunoda H; Hattori K
    Methods Mol Biol; 2019; 1904():213-230. PubMed ID: 30539472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural correspondences between mouse and human immunoglobulin VH genes. Application to the humanization of mouse monoclonal antibodies.
    Poul MA; Lefranc MP
    Ann N Y Acad Sci; 1995 Sep; 764():359-61. PubMed ID: 7486546
    [No Abstract]   [Full Text] [Related]  

  • 5. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanization of monoclonal antibodies by CDR grafting.
    O'Brien S; Jones T
    Methods Mol Biol; 2003; 207():81-100. PubMed ID: 12412469
    [No Abstract]   [Full Text] [Related]  

  • 7. Engineering fully human monoclonal antibodies from murine variable regions.
    Bernett MJ; Karki S; Moore GL; Leung IW; Chen H; Pong E; Nguyen DH; Jacinto J; Zalevsky J; Muchhal US; Desjarlais JR; Lazar GA
    J Mol Biol; 2010 Mar; 396(5):1474-90. PubMed ID: 20045416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of a chicken anti-IL-12 monoclonal antibody.
    Tsurushita N; Park M; Pakabunto K; Ong K; Avdalovic A; Fu H; Jia A; Vásquez M; Kumar S
    J Immunol Methods; 2004 Dec; 295(1-2):9-19. PubMed ID: 15627607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a large synthetic human scFv library with six diversified CDRs and high functional diversity.
    Yang HY; Kang KJ; Chung JE; Shim H
    Mol Cells; 2009 Feb; 27(2):225-35. PubMed ID: 19277506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for phage display selection of functional domain-exchanged immunoglobulin scaffolds with high affinity for glycan targets.
    Stewart A; Liu Y; Lai JR
    J Immunol Methods; 2012 Feb; 376(1-2):150-5. PubMed ID: 22233878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanization of chicken monoclonal antibody using phage-display system.
    Nishibori N; Horiuchi H; Furusawa S; Matsuda H
    Mol Immunol; 2006 Feb; 43(6):634-42. PubMed ID: 16360012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering scFvs for improved stability.
    Chowdhury PS; Vasmatzis G
    Methods Mol Biol; 2003; 207():237-54. PubMed ID: 12412478
    [No Abstract]   [Full Text] [Related]  

  • 13. Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.
    Caldas C; Coelho V; Kalil J; Moro AM; Maranhão AQ; Brígido MM
    Mol Immunol; 2003 May; 39(15):941-52. PubMed ID: 12695120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas.
    Mersmann M; Schmidt A; Rippmann JF; Wüest T; Brocks B; Rettig WJ; Garin-Chesa P; Pfizenmaier K; Moosmayer D
    Int J Cancer; 2001 Apr; 92(2):240-8. PubMed ID: 11291052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage display technology in antibody engineering: design of phagemid vectors and in vitro maturation systems.
    Söderlind E; Simonsson AC; Borrebaeck CA
    Immunol Rev; 1992 Dec; 130():109-24. PubMed ID: 1286867
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
    Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library.
    Gram H; Marconi LA; Barbas CF; Collet TA; Lerner RA; Kang AS
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3576-80. PubMed ID: 1565653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering the variable region of therapeutic IgG antibodies.
    Igawa T; Tsunoda H; Kuramochi T; Sampei Z; Ishii S; Hattori K
    MAbs; 2011; 3(3):243-52. PubMed ID: 21406966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering hot spots for affinity enhancement of antibodies.
    Chowdhury PS
    Methods Mol Biol; 2003; 207():179-96. PubMed ID: 12412475
    [No Abstract]   [Full Text] [Related]  

  • 20. Humanization of antibodies.
    Almagro JC; Fransson J
    Front Biosci; 2008 Jan; 13():1619-33. PubMed ID: 17981654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.